Brighton Jones LLC’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-47,925
Closed -$8.89M 527
2025
Q3
$8.89M Sell
47,925
-9,826
-17% -$1.68M 0.21% 60
2025
Q2
$8.82M Buy
57,751
+3,807
+7% +$585K 0.24% 55
2025
Q1
$8.95M Buy
53,944
+2,068
+4% +$324K 0.29% 51
2024
Q4
$7.5M Buy
51,876
+6,332
+14% +$981K 0.22% 59
2024
Q3
$7.38M Sell
45,544
-3,926
-8% -$626K 0.28% 50
2024
Q2
$7.23M Buy
49,470
+13,078
+36% +$1.95M 0.24% 55
2024
Q1
$5.76M Buy
36,392
+1,362
+4% +$217K 0.21% 65
2023
Q4
$5.49M Sell
35,030
-1,623
-4% -$249K 0.23% 65
2023
Q3
$5.71M Buy
36,653
+309
+0.9% +$51K 0.29% 53
2023
Q2
$6.02M Buy
36,344
+851
+2% +$137K 0.3% 45
2023
Q1
$5.5M Buy
35,493
+3,173
+10% +$512K 0.31% 44
2022
Q4
$5.71M Buy
32,320
+773
+2% +$133K 0.34% 37
2022
Q3
$5.15M Buy
31,547
+1,050
+3% +$178K 0.3% 38
2022
Q2
$5.41M Sell
30,497
-1,875
-6% -$334K 0.31% 37
2022
Q1
$5.74M Buy
32,372
+389
+1% +$66.2K 0.27% 36
2021
Q4
$5.47M Buy
31,983
+1,530
+5% +$250K 0.26% 40
2021
Q3
$4.92M Buy
30,453
+433
+1% +$73.9K 0.25% 44
2021
Q2
$4.95M Sell
30,020
-203
-0.7% -$33.6K 0.25% 43
2021
Q1
$4.97M Buy
30,223
+978
+3% +$158K 0.29% 37
2020
Q4
$4.6M Buy
29,245
+1,487
+5% +$219K 0.28% 38
2020
Q3
$4.13M Buy
27,758
+2,289
+9% +$339K 0.29% 36
2020
Q2
$3.58M Sell
25,469
-1,338
-5% -$195K 0.29% 34
2020
Q1
$3.52M Buy
26,807
+1,523
+6% +$216K 0.37% 28
2019
Q4
$3.69M Buy
25,284
+5,247
+26% +$712K 0.4% 32
2019
Q3
$2.59M Buy
20,037
+775
+4% +$102K 0.3% 40
2019
Q2
$2.68M Sell
19,262
-76
-0.4% -$10.5K 0.31% 40
2019
Q1
$2.7M Sell
19,338
-689
-3% -$92.3K 0.33% 39
2018
Q4
$2.58M Buy
20,027
+365
+2% +$50.9K 0.37% 32
2018
Q3
$2.72M Buy
19,662
+335
+2% +$44.5K 0.33% 32
2018
Q2
$2.35M Buy
19,327
+613
+3% +$76.5K 0.3% 37
2018
Q1
$2.4M Sell
18,714
-517
-3% -$69.9K 0.33% 36
2017
Q4
$2.69M Buy
19,231
+330
+2% +$46K 0.33% 35
2017
Q3
$2.46M Sell
18,901
-136
-0.7% -$18K 0.32% 33
2017
Q2
$2.52M Buy
19,037
+907
+5% +$116K 0.36% 32
2017
Q1
$2.26M Buy
18,130
+13,092
+260% +$1.56M 0.55% 20
2016
Q4
$580K Sell
5,038
-14,011
-74% -$1.62M 0.22% 34
2016
Q3
$2.25M Buy
19,049
+221
+1% +$26.8K 0.36% 35
2016
Q2
$2.28M Buy
18,828
+48
+0.3% +$5.45K 0.4% 29
2016
Q1
$2.03M Buy
18,780
+1,824
+11% +$189K 0.37% 31
2015
Q4
$1.74M Buy
16,956
+559
+3% +$56.2K 0.34% 36
2015
Q3
$1.53M Buy
16,397
+189
+1% +$18.3K 0.33% 38
2015
Q2
$1.58M Buy
16,208
+1,300
+9% +$130K 0.36% 36
2015
Q1
$1.5M Sell
14,908
-383
-3% -$38.9K 0.34% 37
2014
Q4
$1.6M Sell
15,291
-8,384
-35% -$884K 0.37% 39
2014
Q3
$2.52M Buy
23,675
+5,791
+32% +$601K 0.57% 22
2014
Q2
$1.87M Buy
17,884
+202
+1% +$20.4K 0.42% 28
2014
Q1
$1.74M Sell
17,682
-1,596
-8% -$148K 0.41% 30
2013
Q4
$1.71M Buy
19,278
+3,376
+21% +$311K 0.39% 32
2013
Q3
$1.38M Buy
15,902
+2,908
+22% +$261K 0.36% 33
2013
Q2
$1.12M Buy
+12,994
New +$1.1M 0.34% 32

Other funds holding JNJ

Brighton Jones LLC's JNJ Position: Q4 2025 in Review

Brighton Jones LLC sold out of Johnson & Johnson (JNJ) in Q4 2025, closing a stake of 47,925 shares — an estimated $8.89M sold.

Brighton Jones LLC first reported a position in JNJ in Q2 2013 and held it in 50 quarters. The position peaked at $8.95M in Q1 2025. 4,520 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • Brighton Jones LLC reported no remaining Johnson & Johnson position as of Q4 2025 after selling out during the quarter.
  • Brighton Jones LLC sold 47,925 Johnson & Johnson shares in Q4 2025, an estimated $8.89M.
  • Brighton Jones LLC first reported a position in Johnson & Johnson in Q2 2013 and held it in 50 quarters.
  • Brighton Jones LLC's Johnson & Johnson position peaked at $8.95M in Q1 2025.
  • 4,520 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Brighton Jones LLC's 13F filing for Q4 2025, filed 27 Jan 2026.